Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
COMET - Communication and Education in Tumor Profiling: A Randomized Study of Pre-Disclosure Genetic Education v. Usual Care in Tumor Profiling for Advanced Cancer and a Pilot Study of Remote Genetic Counseling for Participants With Potential Germline Mutations Identified on Tumor Profiling
2 other identifiers
interventional
601
1 country
1
Brief Summary
This research trial studies how well pre-test genetic education and remote genetic counseling works in communicating tumor profiling results to patients with advanced cancer. Web-based genetic education before receiving tumor profiling results and remote genetic counseling for patients with potential germline mutations may increase genetic knowledge and reduce distress for patients with advanced cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2016
CompletedFirst Posted
Study publicly available on registry
July 6, 2016
CompletedStudy Start
First participant enrolled
October 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2019
CompletedResults Posted
Study results publicly available
February 28, 2024
CompletedFebruary 28, 2024
December 1, 2023
3.2 years
June 21, 2016
December 21, 2023
January 30, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education
There are 14 items in the questionnaire of Cancer Genetic Knowledge Scale. The total score ranges between 14 and 70. Higher scores indicate more/better knowledge. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education
There are 4 items in the PROMIS - Depression questionnaire. The total score ranges between 4 and 20. Higher scores indicate more depression. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education
There are 4 items in the PROMIS - Anxiety questionnaire. The total score ranges between 4 and 20. Higher scores indicate more anxiety. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)
Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education
There are 14 items in the questionnaire of Impact of Events Scale (IES). The total score ranges between 0 and 70. Higher scores indicate more stress. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Assessed at baseline and up to 14 days post-baseline
Proportion of Participants Who Complete Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)
Among participants who registered in the genetic counseling substudy (Step 2), the proportion of participants who completed remote genetic counseling will be reported. The proportion is defined as "the number of participants who completed remote genetic counseling divided by the number of participants who agreed to participate in the genetic counseling study".
Assessed at baseline at Step 2
Proportion of Participants Who Complete Germline Testing in the Genetic Counseling Substudy (Step 2)
Among participants who registered in the genetic counseling substudy (Step 2), the proportion of participants who completed remote genetic counseling will be reported. The proportion is defined as "the number of participants who completed remote genetic counseling divided by the number of participants who agreed to participate in the genetic counseling study".
Assessed at baseline at Step 2
Secondary Outcomes (4)
Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education by Arm and Sex
Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education by Arm and Sex
Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education by Arm and Sex
Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)
Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education by Arm and Sex
Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)
Other Outcomes (6)
Factors Associated With Uptake of Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)
Assessed at baseline in Step 2
Cognitive and Affective Responses to Confirmatory Germline Testing (Step 2)
Assessed at baseline, within 3 days of remote genetic counseling, within 3 days of germline testing results received, and 3 months after germline testing results received in Step 2
Satisfaction and Regret/Disappointment Related to Tumor Genetic Test Results
Assessed within 3 days of tumor test results received
- +3 more other outcomes
Study Arms (3)
Arm A (Step 1: internet-based intervention)
EXPERIMENTALPatients receive web-based genetic education consisting of general information about testing tumors for genetic mutations.
Arm B (Step 1: usual care control)
ACTIVE COMPARATORPatients receive standard genetic education consisting of conversations with the treating physicians, interaction with and information from the clinical staff, and information from usual resources about testing for genetic mutations.
Step 2 - genetic counseling
EXPERIMENTALPatients who meet the criteria for the remote counseling substudy will receive genetic counseling over the telephone and undergo germline testing.
Interventions
Undergo usual care
Undergo germline testing
Complete on-line genetic education
Ancillary studies
Eligibility Criteria
You may qualify if:
- (STEP 1) - PRIMARY INTERVENTION STUDY (RANDOMIZED CONTROLLED TRIAL \[RCT\]):
- Patients must be registered to the first screening step (Step 0) for the National Cancer Institute (NCI)-MATCH trial (EAY131)
- Patients must speak English and have an adequate ability to view a website (primary intervention study)
- (STEP 2) - SECONDARY GENETIC COUNSELING SUBSTUDY:
- Patients must have a potential germline mutation, as determined by the NCI-MATCH tumor profiling assay
- Patients must be able to speak English and hear by phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ECOG-ACRIN Cancer Research Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
ECOG-ACRIN Cancer Research Group
Philadelphia, Pennsylvania, 19103, United States
Related Publications (1)
Bradbury AR, Lee JW, Gaieski JB, Li S, Gareen IF, Flaherty KT, Herman BA, Domchek SM, DeMichele AM, Maxwell KN, Onitilo AA, Virani S, Park S, Faller BA, Grant SC, Ramaekers RC, Behrens RJ, Nambudiri GS, Carlos RC, Wagner LI. A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152). Cancer. 2022 Apr 1;128(7):1381-1391. doi: 10.1002/cncr.34063. Epub 2021 Dec 10.
PMID: 34890045DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Study Statistician
- Organization
- ECOG-ACRIN Statistical Office
Study Officials
- PRINCIPAL INVESTIGATOR
Angela Bradbury
ECOG-ACRIN Cancer Research Group
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2016
First Posted
July 6, 2016
Study Start
October 25, 2016
Primary Completion
December 26, 2019
Study Completion
December 26, 2019
Last Updated
February 28, 2024
Results First Posted
February 28, 2024
Record last verified: 2023-12